Colorectal cancer has become a rising concern for both men and women, as it’s the second-most common cause of cancer deaths when numbers are combined.

Deadly traffic accidents are up 46% in Nevada since 2013, and they show no sign of slowing. That’s one of many findings out of the Nevada Road Users Database Traffic Study, administered by UNLV’s Kirk Kerkorian School of Medicine.

Florida will work to phase out all childhood vaccine mandates in the state, building on the effort by Republican Gov. Ron DeSantis to curb vaccine requirements and other health mandates during the COVID-19 pandemic.

A push is underway by a top medical professional at a Las Vegas hospital for drivers to slow down, as researchers learn more about traumatic injuries from car crashes in Nevada while trying to improve prevention efforts.

According to a new report from the European Heart Journal, a common heart attack drug doesn't appear to be working as intended and in some cases can even raise the risk of death for some women. To break down the details, Dr. Marc J. Kahn, Professor and Chief of Hematology at the Kirk Kerkorian School of Medicine at UNLV joins us on ARC Las Vegas.

A study from UNLV shows traffic deaths increasing across Nevada, and it may be more than what police can keep up with.

UNLV researchers say they're looking at the companionship between AI and humans.

UNLV has new funding to dig deeper into the sharp rise in deadly crashes on Nevada roads and what can be done to save lives. The Kirk Kerkorian School of Medicine received $650,000 from the Nevada Department of Public Safety to study vehicle crashes.

A UNLV study says traffic deaths in Nevada have increased over a decade span.

The number of traffic deaths and fatal crashes statewide has steadily increased since 2013, and there’s an “urgent need” to address the underlying factors, according to ongoing research done by UNLV’s Kirk Kerkorian School of Medicine.

Pharmaceutical company Eli Lilly announced its new weight loss pill has cleared the latest trial. The company says orforglipron can be used to help people with obesity or those overweight with type 2 diabetes. We start by asking him what these drugs do to the body and the effectiveness.

Life-saving treatment gets counted by minutes, even seconds. Here's how medical staff rushed to save lives, at times even risking their own wellbeing.